March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
New Clues Could Point to Better Treatments for Chronic Graft-Versus-Host Disease (GVHD)
November 9, 2017 | By Katie Neith
City of Hope’s Defu Zeng, professor of diabetes immunology and hematopoietic cell transplantation and colleagues recently uncovered important information about the chronic GVHD.
Novel Treatment May Stop Graft-Versus-Host Disease
April 18, 2017 | Katie Neith
An international team of researchers led by City of Hope’s Defu Zeng believe they may have found a way to prevent graft-versus host disease following stem cell transplants without sacrificing the transplants’ ability to fight leukemia and lymphoma.
How Couples Can Conquer Cancer Together
February 14, 2017 | Dory Benford
The physical, mental and emotional impact of a cancer diagnosis can shake the foundation of even the most solid relationship, but by communicating openly, working together as a team and developing a new normal, the experience can actually bring couples closer than ever before.
Experts offer guidelines to prevent cardiovascular disease post-transplant
September 30, 2016 | Elise Lamar
Bone marrow transplant survivors have significantly higher rates of cardiovascular disease — such as heart failure, stroke, and heart attacks — compared to the general population. Saro Armenian, D.O., M.P.H., is trying to reverse these outcomes.
Patient's 17-year battle with rare blood cancer won’t dim her spirit
January 12, 2016 | Letisia Marquez
Cheryl Taylor spent New Year’s Day in a brand new way. The City of Hope patient watched the Rose Parade from the grandstands, surrounded by strangers who quickly became friends after she told them she’s battled a rare, debilitating blood cancer – a myeloproliferative neoplasm – for almost 17 years.
$2.2 million grant will benefit graft-versus-host disease research
November 20, 2015 | City of Hope
Graft-versus-host disease is a serious condition that affects many people who receive a bone marrow cell transplant. To better fight it, scientists need to better understand it. City of Hope researchers’ efforts to do just that recently got a $2.2 million boost from the National Institute of Allergy and Infectious Diseases, also known as NIAID.
Meet our doctors: Jonathan Cotliar on graft-versus-host disease
February 20, 2015 | Kim Proescholdt
Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor's stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 percent of patients.
A better treatment for graft-versus-host disease? It's possible
February 9, 2015 | Darrin Joy
Cancer patients face a daunting journey marked by challenges and uncertainties. For those undergoing bone marrow, or stem cell, transplantation, one complication poses a particular threat — chronic graft-versus-host disease (GVHD).
She lost brother to graft-versus-host disease; now she fights back
August 9, 2013 | Nicole White
Rosie Mae Henson is continuing a fight she feels her brother John should have won. John successfully conquered his cancer with a bone marrow transplant, but died a year later from graft-versus-host disease in which the new donor cells attack the transplant recipient’s body.